Ciprofloxacin

Restricted
Restricted

C. diff Risk

High

Oral Bioavailability

Good (70 to 90%)

Approximate Cost

IV/PO $

Dosing

10 mg/kg, IV, q12hr(s), Infuse over 60 minutes

CRRTStandard dose, q12hr

Hemodialysis/Peritoneal dialysisStandard dose, q24hr, give after dialysis

< 10 mL/minute/1.73 m2Standard dose, q24hr

10 to 29 mL/minute/1.73 m2Standard dose, q18hr

General Information

Acceptable Uses

Treatment

  • Pyelonephritis

  • Lower respiratory tract infections

  • Skin and soft tissue infections

  • Bone and joint infections

  • Complicated intra-abdominal infections

  • Salmonellosis

  • Infectious diarrhea

  • Febrile neutropenia

  • Endocarditis

Prophylaxis

  • Postexposure prophylaxis of anthrax

  • Surgical site infection

  • Invasive meningococcal disease

Unacceptable Uses

  • Most gram positives

  • Stenotrophomonas

  • Anaerobes

Drug Monitoring

Renal and liver function, CBC periodically

Adverse Effects

  • Dizziness

  • Insomnia

  • Rash

  • N/V

  • Abdominal pain

  • Tendinopathy and rupture

  • Retinal detachment

  • Peripheral neuropathy

  • QTc prolongation

Major Interactions

  • Strong CYP1A2 inhibitor and weak CYP3A4 inhibitor - Multiple interactions possible

  • QTc prolongation - Increased risk with other agents that prolong QTc

  • AVOID concomitant administration with antacids, multivitamin & mineral supplements - Space doses by 2 hours

Oral Liquids

500mg/5ml suspension

Tablet/Capsule Strengths

250mg tablet
500mg tablet
750mg tablet

Additional Information

Do not administer supsension through feeding tubes. Crush and mix tablet instead

Pharmacology

Antimicrobial class: Fluoroquinolone

Pregnancy category: C

Average serum half life: Pediatrics: 4-5 hours

Biliary penetration: Good

CSF penetration: 26%

Lung penetration: Excellent

Urine penetration: Excellent kidney penetration

Route of Elimination: 30% to 70% excreted as unchanged drug in urine via glomerular filtration and active tubular secretion; 20% excreted in feces primarily from biliary excretion; <1% excreted in bile as unchanged drug

Metabolism: Partially hepatic